nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Rivaroxaban—CYP3A5—prostate cancer	0.00904	0.698	CrCbGaD
Linezolid—Rivaroxaban—CYP3A4—prostate cancer	0.00391	0.302	CrCbGaD
Linezolid—MAOB—prostate gland—prostate cancer	0.00309	0.136	CbGeAlD
Linezolid—MAOA—prostate gland—prostate cancer	0.00264	0.116	CbGeAlD
Linezolid—MAOB—seminal vesicle—prostate cancer	0.00261	0.115	CbGeAlD
Linezolid—MAOA—seminal vesicle—prostate cancer	0.00223	0.0984	CbGeAlD
Linezolid—MAOB—renal system—prostate cancer	0.00211	0.093	CbGeAlD
Linezolid—MAOB—urethra—prostate cancer	0.00207	0.0913	CbGeAlD
Linezolid—MAOA—renal system—prostate cancer	0.0018	0.0793	CbGeAlD
Linezolid—MAOA—urethra—prostate cancer	0.00177	0.0779	CbGeAlD
Linezolid—MAOB—testis—prostate cancer	0.00136	0.0601	CbGeAlD
Linezolid—MAOA—testis—prostate cancer	0.00116	0.0513	CbGeAlD
Linezolid—MAOB—lymph node—prostate cancer	0.000987	0.0436	CbGeAlD
Linezolid—MAOA—lymph node—prostate cancer	0.000842	0.0372	CbGeAlD
Linezolid—MAOA—Biological oxidations—GSTT1—prostate cancer	0.000477	0.00165	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GNG5—prostate cancer	0.000474	0.00164	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP2A6—prostate cancer	0.000472	0.00163	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP1A1—prostate cancer	0.000459	0.00159	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.000459	0.00159	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HAO1—prostate cancer	0.000453	0.00157	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP17A1—prostate cancer	0.000452	0.00156	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—NCOA2—prostate cancer	0.00043	0.00149	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.000426	0.00147	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—ACHE—prostate cancer	0.000423	0.00146	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TH—prostate cancer	0.000423	0.00146	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.000404	0.0014	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP2E1—prostate cancer	0.000401	0.00139	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—PLCB2—prostate cancer	0.000401	0.00139	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.000398	0.00138	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP3A4—prostate cancer	0.000387	0.00134	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—SLC22A1—prostate cancer	0.000382	0.00132	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP1B1—prostate cancer	0.00038	0.00132	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.000379	0.00131	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—AR—prostate cancer	0.000376	0.0013	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TST—prostate cancer	0.000369	0.00128	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CSAD—prostate cancer	0.000369	0.00128	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PSAT1—prostate cancer	0.000369	0.00128	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADI1—prostate cancer	0.000369	0.00128	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CBR1—prostate cancer	0.000369	0.00128	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GRHL1—prostate cancer	0.000369	0.00128	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GGT1—prostate cancer	0.000368	0.00127	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GNG5—prostate cancer	0.000364	0.00126	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—NCOA1—prostate cancer	0.000363	0.00126	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP19A1—prostate cancer	0.000357	0.00124	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—RXRA—prostate cancer	0.000345	0.00119	CbGpPWpGaD
Linezolid—MAOB—Metabolism—UGT2B15—prostate cancer	0.000343	0.00119	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GRHPR—prostate cancer	0.000343	0.00119	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CKMT2—prostate cancer	0.000343	0.00119	CbGpPWpGaD
Linezolid—MAOB—Metabolism—UGT2B17—prostate cancer	0.000343	0.00119	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—COMT—prostate cancer	0.000332	0.00115	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTP1—prostate cancer	0.000331	0.00115	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000329	0.00114	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—ACHE—prostate cancer	0.000324	0.00112	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PGAM2—prostate cancer	0.000323	0.00112	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NAGLU—prostate cancer	0.000323	0.00112	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MBTPS1—prostate cancer	0.000323	0.00112	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AOX1—prostate cancer	0.000323	0.00112	CbGpPWpGaD
Linezolid—MAOB—Metabolism—RFK—prostate cancer	0.000323	0.00112	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SULT2B1—prostate cancer	0.000323	0.00112	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTM3—prostate cancer	0.000323	0.00112	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—PRKACB—prostate cancer	0.00031	0.00107	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AMACR—prostate cancer	0.000306	0.00106	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP3A43—prostate cancer	0.000306	0.00106	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SRD5A2—prostate cancer	0.000306	0.00106	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NAT1—prostate cancer	0.000306	0.00106	CbGpPWpGaD
Linezolid—MAOB—Metabolism—DEGS1—prostate cancer	0.000306	0.00106	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000304	0.00105	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTM1—prostate cancer	0.000304	0.00105	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—COMT—prostate cancer	0.000295	0.00102	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HSD17B1—prostate cancer	0.000292	0.00101	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP1A1—prostate cancer	0.000288	0.000998	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HAO1—prostate cancer	0.000284	0.000985	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000277	0.000959	CbGpPWpGaD
Linezolid—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000268	0.000397	CcSEcCtD
Linezolid—Muscle spasms—Capecitabine—prostate cancer	0.000267	0.000396	CcSEcCtD
Linezolid—Anaemia—Docetaxel—prostate cancer	0.000265	0.000393	CcSEcCtD
Linezolid—Pancytopenia—Epirubicin—prostate cancer	0.000264	0.000391	CcSEcCtD
Linezolid—Gastritis—Doxorubicin—prostate cancer	0.000263	0.00039	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000262	0.000388	CcSEcCtD
Linezolid—Vision blurred—Capecitabine—prostate cancer	0.000262	0.000388	CcSEcCtD
Linezolid—Asthenia—Estradiol—prostate cancer	0.000261	0.000386	CcSEcCtD
Linezolid—MAOB—Metabolism—B4GALT4—prostate cancer	0.00026	0.000901	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HPGD—prostate cancer	0.00026	0.000901	CbGpPWpGaD
Linezolid—Neutropenia—Epirubicin—prostate cancer	0.00026	0.000385	CcSEcCtD
Linezolid—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000258	0.000382	CcSEcCtD
Linezolid—Pruritus—Estradiol—prostate cancer	0.000257	0.000381	CcSEcCtD
Linezolid—Leukopenia—Docetaxel—prostate cancer	0.000257	0.00038	CcSEcCtD
Linezolid—Anaemia—Capecitabine—prostate cancer	0.000257	0.00038	CcSEcCtD
Linezolid—Eosinophilia—Doxorubicin—prostate cancer	0.000255	0.000377	CcSEcCtD
Linezolid—Paraesthesia—Etoposide—prostate cancer	0.000253	0.000375	CcSEcCtD
Linezolid—Pancreatitis—Doxorubicin—prostate cancer	0.000252	0.000373	CcSEcCtD
Linezolid—Dyspnoea—Etoposide—prostate cancer	0.000251	0.000372	CcSEcCtD
Linezolid—Hyperglycaemia—Epirubicin—prostate cancer	0.000251	0.000371	CcSEcCtD
Linezolid—Somnolence—Etoposide—prostate cancer	0.000251	0.000371	CcSEcCtD
Linezolid—Cough—Docetaxel—prostate cancer	0.000251	0.000371	CcSEcCtD
Linezolid—Vertigo—Capecitabine—prostate cancer	0.00025	0.00037	CcSEcCtD
Linezolid—Pneumonia—Epirubicin—prostate cancer	0.000249	0.000369	CcSEcCtD
Linezolid—Diarrhoea—Estradiol—prostate cancer	0.000249	0.000368	CcSEcCtD
Linezolid—Leukopenia—Capecitabine—prostate cancer	0.000249	0.000368	CcSEcCtD
Linezolid—Convulsion—Docetaxel—prostate cancer	0.000249	0.000368	CcSEcCtD
Linezolid—Hypertension—Docetaxel—prostate cancer	0.000248	0.000367	CcSEcCtD
Linezolid—Erythema—Prednisone—prostate cancer	0.000248	0.000367	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000246	0.000364	CcSEcCtD
Linezolid—Decreased appetite—Etoposide—prostate cancer	0.000245	0.000363	CcSEcCtD
Linezolid—MAOB—Metabolism—TNFRSF21—prostate cancer	0.000245	0.000847	CbGpPWpGaD
Linezolid—Pancytopenia—Doxorubicin—prostate cancer	0.000244	0.000361	CcSEcCtD
Linezolid—Renal failure—Epirubicin—prostate cancer	0.000244	0.000361	CcSEcCtD
Linezolid—Gastrointestinal disorder—Etoposide—prostate cancer	0.000243	0.00036	CcSEcCtD
Linezolid—Asthenia—Mitoxantrone—prostate cancer	0.000243	0.00036	CcSEcCtD
Linezolid—Fatigue—Etoposide—prostate cancer	0.000243	0.00036	CcSEcCtD
Linezolid—Neuropathy peripheral—Epirubicin—prostate cancer	0.000243	0.00036	CcSEcCtD
Linezolid—Cough—Capecitabine—prostate cancer	0.000243	0.000359	CcSEcCtD
Linezolid—Stomatitis—Epirubicin—prostate cancer	0.000242	0.000358	CcSEcCtD
Linezolid—Pain—Etoposide—prostate cancer	0.000241	0.000357	CcSEcCtD
Linezolid—Constipation—Etoposide—prostate cancer	0.000241	0.000357	CcSEcCtD
Linezolid—Dizziness—Estradiol—prostate cancer	0.000241	0.000356	CcSEcCtD
Linezolid—Neutropenia—Doxorubicin—prostate cancer	0.00024	0.000356	CcSEcCtD
Linezolid—Hypertension—Capecitabine—prostate cancer	0.00024	0.000355	CcSEcCtD
Linezolid—Dry mouth—Docetaxel—prostate cancer	0.000239	0.000354	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000239	0.000354	CcSEcCtD
Linezolid—MAOB—Metabolism—CYP7B1—prostate cancer	0.000238	0.000824	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MTAP—prostate cancer	0.000238	0.000824	CbGpPWpGaD
Linezolid—Anaphylactic shock—Docetaxel—prostate cancer	0.000234	0.000347	CcSEcCtD
Linezolid—Vision blurred—Prednisone—prostate cancer	0.000233	0.000345	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—prostate cancer	0.000232	0.000343	CcSEcCtD
Linezolid—MAOB—Metabolism—SULT1E1—prostate cancer	0.000232	0.000803	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SRD5A1—prostate cancer	0.000232	0.000803	CbGpPWpGaD
Linezolid—Diarrhoea—Mitoxantrone—prostate cancer	0.000232	0.000343	CcSEcCtD
Linezolid—MAOA—Metabolism—ADI1—prostate cancer	0.000232	0.000803	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CSAD—prostate cancer	0.000232	0.000803	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TST—prostate cancer	0.000232	0.000803	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GRHL1—prostate cancer	0.000232	0.000803	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PSAT1—prostate cancer	0.000232	0.000803	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CBR1—prostate cancer	0.000232	0.000803	CbGpPWpGaD
Linezolid—Dry mouth—Capecitabine—prostate cancer	0.000231	0.000343	CcSEcCtD
Linezolid—Vomiting—Estradiol—prostate cancer	0.000231	0.000342	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—prostate cancer	0.000231	0.000341	CcSEcCtD
Linezolid—Gastrointestinal pain—Etoposide—prostate cancer	0.000231	0.000341	CcSEcCtD
Linezolid—Thrombocytopenia—Docetaxel—prostate cancer	0.000229	0.00034	CcSEcCtD
Linezolid—Rash—Estradiol—prostate cancer	0.000229	0.00034	CcSEcCtD
Linezolid—Dermatitis—Estradiol—prostate cancer	0.000229	0.000339	CcSEcCtD
Linezolid—Anaemia—Prednisone—prostate cancer	0.000229	0.000339	CcSEcCtD
Linezolid—Headache—Estradiol—prostate cancer	0.000228	0.000337	CcSEcCtD
Linezolid—Skin disorder—Docetaxel—prostate cancer	0.000228	0.000337	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000227	0.000336	CcSEcCtD
Linezolid—Angioedema—Prednisone—prostate cancer	0.000226	0.000335	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000226	0.000783	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—COMT—prostate cancer	0.000226	0.000781	CbGpPWpGaD
Linezolid—Renal failure—Doxorubicin—prostate cancer	0.000225	0.000334	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000225	0.000333	CcSEcCtD
Linezolid—Urticaria—Etoposide—prostate cancer	0.000224	0.000332	CcSEcCtD
Linezolid—Haemoglobin—Epirubicin—prostate cancer	0.000224	0.000331	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—prostate cancer	0.000224	0.000331	CcSEcCtD
Linezolid—Anorexia—Docetaxel—prostate cancer	0.000223	0.000331	CcSEcCtD
Linezolid—Body temperature increased—Etoposide—prostate cancer	0.000223	0.00033	CcSEcCtD
Linezolid—Abdominal pain—Etoposide—prostate cancer	0.000223	0.00033	CcSEcCtD
Linezolid—Vertigo—Prednisone—prostate cancer	0.000222	0.000329	CcSEcCtD
Linezolid—Haemorrhage—Epirubicin—prostate cancer	0.000222	0.000329	CcSEcCtD
Linezolid—Thrombocytopenia—Capecitabine—prostate cancer	0.000222	0.000329	CcSEcCtD
Linezolid—Hypoaesthesia—Epirubicin—prostate cancer	0.000221	0.000328	CcSEcCtD
Linezolid—MAOB—Metabolism—ACSL4—prostate cancer	0.000221	0.000766	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HSD17B3—prostate cancer	0.000221	0.000766	CbGpPWpGaD
Linezolid—Pharyngitis—Epirubicin—prostate cancer	0.000221	0.000327	CcSEcCtD
Linezolid—Skin disorder—Capecitabine—prostate cancer	0.00022	0.000326	CcSEcCtD
Linezolid—Hyperhidrosis—Capecitabine—prostate cancer	0.000219	0.000325	CcSEcCtD
Linezolid—Anorexia—Capecitabine—prostate cancer	0.000216	0.00032	CcSEcCtD
Linezolid—Nausea—Estradiol—prostate cancer	0.000216	0.00032	CcSEcCtD
Linezolid—Vomiting—Mitoxantrone—prostate cancer	0.000216	0.000319	CcSEcCtD
Linezolid—MAOA—Metabolism—GRHPR—prostate cancer	0.000215	0.000746	CbGpPWpGaD
Linezolid—MAOA—Metabolism—UGT2B17—prostate cancer	0.000215	0.000746	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CKMT2—prostate cancer	0.000215	0.000746	CbGpPWpGaD
Linezolid—MAOA—Metabolism—UGT2B15—prostate cancer	0.000215	0.000746	CbGpPWpGaD
Linezolid—Convulsion—Prednisone—prostate cancer	0.000215	0.000318	CcSEcCtD
Linezolid—Hypertension—Prednisone—prostate cancer	0.000214	0.000316	CcSEcCtD
Linezolid—Rash—Mitoxantrone—prostate cancer	0.000214	0.000316	CcSEcCtD
Linezolid—Dermatitis—Mitoxantrone—prostate cancer	0.000214	0.000316	CcSEcCtD
Linezolid—Headache—Mitoxantrone—prostate cancer	0.000212	0.000314	CcSEcCtD
Linezolid—MAOB—Metabolism—UMPS—prostate cancer	0.000212	0.000735	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PHGDH—prostate cancer	0.000212	0.000735	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ARG2—prostate cancer	0.000212	0.000735	CbGpPWpGaD
Linezolid—Insomnia—Docetaxel—prostate cancer	0.000212	0.000314	CcSEcCtD
Linezolid—Paraesthesia—Docetaxel—prostate cancer	0.00021	0.000311	CcSEcCtD
Linezolid—Erythema multiforme—Epirubicin—prostate cancer	0.00021	0.000311	CcSEcCtD
Linezolid—Dyspnoea—Docetaxel—prostate cancer	0.000209	0.000309	CcSEcCtD
Linezolid—Somnolence—Docetaxel—prostate cancer	0.000208	0.000308	CcSEcCtD
Linezolid—MAOB—Metabolism—LDHB—prostate cancer	0.000208	0.00072	CbGpPWpGaD
Linezolid—Tinnitus—Epirubicin—prostate cancer	0.000207	0.000307	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—prostate cancer	0.000207	0.000306	CcSEcCtD
Linezolid—Dyspepsia—Docetaxel—prostate cancer	0.000206	0.000305	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—prostate cancer	0.000206	0.000305	CcSEcCtD
Linezolid—Insomnia—Capecitabine—prostate cancer	0.000205	0.000304	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—prostate cancer	0.000205	0.000303	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—prostate cancer	0.000204	0.000302	CcSEcCtD
Linezolid—MAOB—Metabolism—CYP3A5—prostate cancer	0.000204	0.000707	CbGpPWpGaD
Linezolid—Paraesthesia—Capecitabine—prostate cancer	0.000204	0.000302	CcSEcCtD
Linezolid—Decreased appetite—Docetaxel—prostate cancer	0.000204	0.000302	CcSEcCtD
Linezolid—MAOA—Metabolism—PGAM2—prostate cancer	0.000203	0.000702	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AOX1—prostate cancer	0.000203	0.000702	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SULT2B1—prostate cancer	0.000203	0.000702	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NAGLU—prostate cancer	0.000203	0.000702	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTM3—prostate cancer	0.000203	0.000702	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MBTPS1—prostate cancer	0.000203	0.000702	CbGpPWpGaD
Linezolid—MAOA—Metabolism—RFK—prostate cancer	0.000203	0.000702	CbGpPWpGaD
Linezolid—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000202	0.000299	CcSEcCtD
Linezolid—Asthenia—Etoposide—prostate cancer	0.000202	0.000299	CcSEcCtD
Linezolid—Dyspnoea—Capecitabine—prostate cancer	0.000202	0.000299	CcSEcCtD
Linezolid—Anaphylactic shock—Prednisone—prostate cancer	0.000202	0.000299	CcSEcCtD
Linezolid—Fatigue—Docetaxel—prostate cancer	0.000202	0.000299	CcSEcCtD
Linezolid—Nausea—Mitoxantrone—prostate cancer	0.000201	0.000298	CcSEcCtD
Linezolid—Constipation—Docetaxel—prostate cancer	0.0002	0.000297	CcSEcCtD
Linezolid—Pain—Docetaxel—prostate cancer	0.0002	0.000297	CcSEcCtD
Linezolid—Dyspepsia—Capecitabine—prostate cancer	0.0002	0.000296	CcSEcCtD
Linezolid—Chills—Epirubicin—prostate cancer	0.0002	0.000295	CcSEcCtD
Linezolid—Pruritus—Etoposide—prostate cancer	0.000199	0.000295	CcSEcCtD
Linezolid—MAOB—Metabolism—PDHA1—prostate cancer	0.000197	0.000683	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTA3—prostate cancer	0.000197	0.000683	CbGpPWpGaD
Linezolid—MAOB—Metabolism—UCP3—prostate cancer	0.000197	0.000683	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TCN2—prostate cancer	0.000197	0.000683	CbGpPWpGaD
Linezolid—Decreased appetite—Capecitabine—prostate cancer	0.000197	0.000292	CcSEcCtD
Linezolid—Skin disorder—Prednisone—prostate cancer	0.000196	0.000291	CcSEcCtD
Linezolid—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000196	0.00029	CcSEcCtD
Linezolid—Fatigue—Capecitabine—prostate cancer	0.000196	0.00029	CcSEcCtD
Linezolid—Hyperhidrosis—Prednisone—prostate cancer	0.000195	0.000289	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—prostate cancer	0.000195	0.000288	CcSEcCtD
Linezolid—Pain—Capecitabine—prostate cancer	0.000194	0.000287	CcSEcCtD
Linezolid—Constipation—Capecitabine—prostate cancer	0.000194	0.000287	CcSEcCtD
Linezolid—Erythema—Epirubicin—prostate cancer	0.000194	0.000287	CcSEcCtD
Linezolid—Diarrhoea—Etoposide—prostate cancer	0.000193	0.000286	CcSEcCtD
Linezolid—Anorexia—Prednisone—prostate cancer	0.000193	0.000285	CcSEcCtD
Linezolid—MAOA—Metabolism—CYP3A43—prostate cancer	0.000192	0.000665	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AMACR—prostate cancer	0.000192	0.000665	CbGpPWpGaD
Linezolid—MAOA—Metabolism—DEGS1—prostate cancer	0.000192	0.000665	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NAT1—prostate cancer	0.000192	0.000665	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SRD5A2—prostate cancer	0.000192	0.000665	CbGpPWpGaD
Linezolid—Tinnitus—Doxorubicin—prostate cancer	0.000192	0.000284	CcSEcCtD
Linezolid—Gastrointestinal pain—Docetaxel—prostate cancer	0.000192	0.000284	CcSEcCtD
Linezolid—Flatulence—Epirubicin—prostate cancer	0.000191	0.000282	CcSEcCtD
Linezolid—Dysgeusia—Epirubicin—prostate cancer	0.00019	0.000281	CcSEcCtD
Linezolid—MAOB—Metabolism—SLC22A3—prostate cancer	0.000188	0.000652	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HSD3B1—prostate cancer	0.000188	0.000652	CbGpPWpGaD
Linezolid—Dizziness—Etoposide—prostate cancer	0.000186	0.000276	CcSEcCtD
Linezolid—Muscle spasms—Epirubicin—prostate cancer	0.000186	0.000276	CcSEcCtD
Linezolid—Gastrointestinal pain—Capecitabine—prostate cancer	0.000186	0.000275	CcSEcCtD
Linezolid—Abdominal pain—Docetaxel—prostate cancer	0.000185	0.000274	CcSEcCtD
Linezolid—Body temperature increased—Docetaxel—prostate cancer	0.000185	0.000274	CcSEcCtD
Linezolid—Chills—Doxorubicin—prostate cancer	0.000185	0.000273	CcSEcCtD
Linezolid—MAOA—Metabolism—HSD17B1—prostate cancer	0.000183	0.000634	CbGpPWpGaD
Linezolid—Insomnia—Prednisone—prostate cancer	0.000183	0.000271	CcSEcCtD
Linezolid—Vision blurred—Epirubicin—prostate cancer	0.000183	0.00027	CcSEcCtD
Linezolid—Paraesthesia—Prednisone—prostate cancer	0.000181	0.000269	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTA4—prostate cancer	0.00018	0.000625	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TBXAS1—prostate cancer	0.00018	0.000625	CbGpPWpGaD
Linezolid—Urticaria—Capecitabine—prostate cancer	0.00018	0.000267	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.00018	0.000622	CbGpPWpGaD
Linezolid—Abdominal pain—Capecitabine—prostate cancer	0.000179	0.000265	CcSEcCtD
Linezolid—Body temperature increased—Capecitabine—prostate cancer	0.000179	0.000265	CcSEcCtD
Linezolid—Vomiting—Etoposide—prostate cancer	0.000179	0.000265	CcSEcCtD
Linezolid—Erythema—Doxorubicin—prostate cancer	0.000179	0.000265	CcSEcCtD
Linezolid—Anaemia—Epirubicin—prostate cancer	0.000179	0.000265	CcSEcCtD
Linezolid—Dyspepsia—Prednisone—prostate cancer	0.000178	0.000263	CcSEcCtD
Linezolid—Rash—Etoposide—prostate cancer	0.000178	0.000263	CcSEcCtD
Linezolid—Dermatitis—Etoposide—prostate cancer	0.000178	0.000263	CcSEcCtD
Linezolid—Headache—Etoposide—prostate cancer	0.000177	0.000261	CcSEcCtD
Linezolid—Flatulence—Doxorubicin—prostate cancer	0.000177	0.000261	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTA2—prostate cancer	0.000176	0.000609	CbGpPWpGaD
Linezolid—Decreased appetite—Prednisone—prostate cancer	0.000176	0.00026	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—prostate cancer	0.000175	0.00026	CcSEcCtD
Linezolid—Fatigue—Prednisone—prostate cancer	0.000174	0.000258	CcSEcCtD
Linezolid—Vertigo—Epirubicin—prostate cancer	0.000174	0.000258	CcSEcCtD
Linezolid—MAOB—Metabolism—SULT1A1—prostate cancer	0.000174	0.000601	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCG5—prostate cancer	0.000174	0.000601	CbGpPWpGaD
Linezolid—Leukopenia—Epirubicin—prostate cancer	0.000173	0.000257	CcSEcCtD
Linezolid—Constipation—Prednisone—prostate cancer	0.000173	0.000256	CcSEcCtD
Linezolid—Muscle spasms—Doxorubicin—prostate cancer	0.000172	0.000255	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000172	0.000595	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTA1—prostate cancer	0.00017	0.000587	CbGpPWpGaD
Linezolid—Cough—Epirubicin—prostate cancer	0.000169	0.00025	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—prostate cancer	0.000169	0.00025	CcSEcCtD
Linezolid—Asthenia—Docetaxel—prostate cancer	0.000168	0.000249	CcSEcCtD
Linezolid—Convulsion—Epirubicin—prostate cancer	0.000168	0.000248	CcSEcCtD
Linezolid—MAOB—Metabolism—HSD3B2—prostate cancer	0.000168	0.000581	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NAT2—prostate cancer	0.000168	0.000581	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTO1—prostate cancer	0.000168	0.000581	CbGpPWpGaD
Linezolid—Nausea—Etoposide—prostate cancer	0.000167	0.000248	CcSEcCtD
Linezolid—Hypertension—Epirubicin—prostate cancer	0.000167	0.000247	CcSEcCtD
Linezolid—Pruritus—Docetaxel—prostate cancer	0.000166	0.000245	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000166	0.000574	CbGpPWpGaD
Linezolid—Anaemia—Doxorubicin—prostate cancer	0.000166	0.000245	CcSEcCtD
Linezolid—Gastrointestinal pain—Prednisone—prostate cancer	0.000165	0.000245	CcSEcCtD
Linezolid—MAOA—Metabolism—B4GALT4—prostate cancer	0.000163	0.000565	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HPGD—prostate cancer	0.000163	0.000565	CbGpPWpGaD
Linezolid—Asthenia—Capecitabine—prostate cancer	0.000163	0.000241	CcSEcCtD
Linezolid—Dry mouth—Epirubicin—prostate cancer	0.000161	0.000239	CcSEcCtD
Linezolid—Vertigo—Doxorubicin—prostate cancer	0.000161	0.000238	CcSEcCtD
Linezolid—MAOB—Metabolism—PLCB2—prostate cancer	0.000161	0.000557	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LRP2—prostate cancer	0.000161	0.000557	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2C18—prostate cancer	0.000161	0.000557	CbGpPWpGaD
Linezolid—Urticaria—Prednisone—prostate cancer	0.000161	0.000238	CcSEcCtD
Linezolid—Pruritus—Capecitabine—prostate cancer	0.000161	0.000238	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—prostate cancer	0.00016	0.000237	CcSEcCtD
Linezolid—Diarrhoea—Docetaxel—prostate cancer	0.00016	0.000237	CcSEcCtD
Linezolid—Body temperature increased—Prednisone—prostate cancer	0.00016	0.000236	CcSEcCtD
Linezolid—Abdominal pain—Prednisone—prostate cancer	0.00016	0.000236	CcSEcCtD
Linezolid—Anaphylactic shock—Epirubicin—prostate cancer	0.000158	0.000234	CcSEcCtD
Linezolid—MAOB—Metabolism—P4HB—prostate cancer	0.000158	0.000546	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000158	0.000545	CbGpPWpGaD
Linezolid—Cough—Doxorubicin—prostate cancer	0.000156	0.000231	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—prostate cancer	0.000155	0.00023	CcSEcCtD
Linezolid—Diarrhoea—Capecitabine—prostate cancer	0.000155	0.00023	CcSEcCtD
Linezolid—Dizziness—Docetaxel—prostate cancer	0.000155	0.000229	CcSEcCtD
Linezolid—Thrombocytopenia—Epirubicin—prostate cancer	0.000155	0.000229	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—prostate cancer	0.000155	0.000229	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000154	0.000534	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TNFRSF21—prostate cancer	0.000154	0.000532	CbGpPWpGaD
Linezolid—Skin disorder—Epirubicin—prostate cancer	0.000154	0.000227	CcSEcCtD
Linezolid—MAOB—Metabolism—SLC22A1—prostate cancer	0.000153	0.000531	CbGpPWpGaD
Linezolid—Hyperhidrosis—Epirubicin—prostate cancer	0.000153	0.000226	CcSEcCtD
Linezolid—Anorexia—Epirubicin—prostate cancer	0.000151	0.000223	CcSEcCtD
Linezolid—Dizziness—Capecitabine—prostate cancer	0.00015	0.000222	CcSEcCtD
Linezolid—MAOB—Metabolism—SULT2A1—prostate cancer	0.000149	0.000518	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTAP—prostate cancer	0.000149	0.000517	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP7B1—prostate cancer	0.000149	0.000517	CbGpPWpGaD
Linezolid—Dry mouth—Doxorubicin—prostate cancer	0.000149	0.000221	CcSEcCtD
Linezolid—Vomiting—Docetaxel—prostate cancer	0.000149	0.000221	CcSEcCtD
Linezolid—Rash—Docetaxel—prostate cancer	0.000148	0.000219	CcSEcCtD
Linezolid—Dermatitis—Docetaxel—prostate cancer	0.000148	0.000218	CcSEcCtD
Linezolid—MAOB—Metabolism—MED12—prostate cancer	0.000147	0.000509	CbGpPWpGaD
Linezolid—Headache—Docetaxel—prostate cancer	0.000147	0.000217	CcSEcCtD
Linezolid—Anaphylactic shock—Doxorubicin—prostate cancer	0.000146	0.000216	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000146	0.000505	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GNG5—prostate cancer	0.000146	0.000505	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SULT1E1—prostate cancer	0.000146	0.000504	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SRD5A1—prostate cancer	0.000146	0.000504	CbGpPWpGaD
Linezolid—Asthenia—Prednisone—prostate cancer	0.000145	0.000215	CcSEcCtD
Linezolid—Vomiting—Capecitabine—prostate cancer	0.000144	0.000214	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—prostate cancer	0.000143	0.000212	CcSEcCtD
Linezolid—Rash—Capecitabine—prostate cancer	0.000143	0.000212	CcSEcCtD
Linezolid—Pruritus—Prednisone—prostate cancer	0.000143	0.000212	CcSEcCtD
Linezolid—Insomnia—Epirubicin—prostate cancer	0.000143	0.000212	CcSEcCtD
Linezolid—Dermatitis—Capecitabine—prostate cancer	0.000143	0.000212	CcSEcCtD
Linezolid—Headache—Capecitabine—prostate cancer	0.000142	0.00021	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—prostate cancer	0.000142	0.00021	CcSEcCtD
Linezolid—Paraesthesia—Epirubicin—prostate cancer	0.000142	0.00021	CcSEcCtD
Linezolid—Hyperhidrosis—Doxorubicin—prostate cancer	0.000141	0.000209	CcSEcCtD
Linezolid—Dyspnoea—Epirubicin—prostate cancer	0.000141	0.000209	CcSEcCtD
Linezolid—MAOB—Metabolism—NCOA3—prostate cancer	0.000141	0.000487	CbGpPWpGaD
Linezolid—Somnolence—Epirubicin—prostate cancer	0.000141	0.000208	CcSEcCtD
Linezolid—Anorexia—Doxorubicin—prostate cancer	0.000139	0.000206	CcSEcCtD
Linezolid—Nausea—Docetaxel—prostate cancer	0.000139	0.000206	CcSEcCtD
Linezolid—Dyspepsia—Epirubicin—prostate cancer	0.000139	0.000206	CcSEcCtD
Linezolid—MAOA—Metabolism—ACSL4—prostate cancer	0.000139	0.000481	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HSD17B3—prostate cancer	0.000139	0.000481	CbGpPWpGaD
Linezolid—Diarrhoea—Prednisone—prostate cancer	0.000138	0.000205	CcSEcCtD
Linezolid—Decreased appetite—Epirubicin—prostate cancer	0.000137	0.000203	CcSEcCtD
Linezolid—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000136	0.000202	CcSEcCtD
Linezolid—Fatigue—Epirubicin—prostate cancer	0.000136	0.000202	CcSEcCtD
Linezolid—Constipation—Epirubicin—prostate cancer	0.000135	0.0002	CcSEcCtD
Linezolid—Pain—Epirubicin—prostate cancer	0.000135	0.0002	CcSEcCtD
Linezolid—Nausea—Capecitabine—prostate cancer	0.000135	0.000199	CcSEcCtD
Linezolid—MAOB—Metabolism—HPGDS—prostate cancer	0.000134	0.000464	CbGpPWpGaD
Linezolid—Dizziness—Prednisone—prostate cancer	0.000134	0.000198	CcSEcCtD
Linezolid—MAOB—Metabolism—CYP2C19—prostate cancer	0.000133	0.000461	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PHGDH—prostate cancer	0.000133	0.000461	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ARG2—prostate cancer	0.000133	0.000461	CbGpPWpGaD
Linezolid—MAOA—Metabolism—UMPS—prostate cancer	0.000133	0.000461	CbGpPWpGaD
Linezolid—Insomnia—Doxorubicin—prostate cancer	0.000132	0.000196	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—prostate cancer	0.000131	0.000194	CcSEcCtD
Linezolid—MAOA—Metabolism—LDHB—prostate cancer	0.000131	0.000452	CbGpPWpGaD
Linezolid—Dyspnoea—Doxorubicin—prostate cancer	0.00013	0.000193	CcSEcCtD
Linezolid—MAOB—Metabolism—GSTT1—prostate cancer	0.00013	0.00045	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ACHE—prostate cancer	0.00013	0.00045	CbGpPWpGaD
Linezolid—Somnolence—Doxorubicin—prostate cancer	0.00013	0.000192	CcSEcCtD
Linezolid—Gastrointestinal pain—Epirubicin—prostate cancer	0.000129	0.000191	CcSEcCtD
Linezolid—Dyspepsia—Doxorubicin—prostate cancer	0.000129	0.000191	CcSEcCtD
Linezolid—MAOB—Metabolism—CYP2A6—prostate cancer	0.000129	0.000445	CbGpPWpGaD
Linezolid—Vomiting—Prednisone—prostate cancer	0.000128	0.00019	CcSEcCtD
Linezolid—MAOA—Metabolism—CYP3A5—prostate cancer	0.000128	0.000444	CbGpPWpGaD
Linezolid—Rash—Prednisone—prostate cancer	0.000127	0.000189	CcSEcCtD
Linezolid—Dermatitis—Prednisone—prostate cancer	0.000127	0.000188	CcSEcCtD
Linezolid—Decreased appetite—Doxorubicin—prostate cancer	0.000127	0.000188	CcSEcCtD
Linezolid—Headache—Prednisone—prostate cancer	0.000127	0.000187	CcSEcCtD
Linezolid—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000126	0.000187	CcSEcCtD
Linezolid—Fatigue—Doxorubicin—prostate cancer	0.000126	0.000187	CcSEcCtD
Linezolid—Urticaria—Epirubicin—prostate cancer	0.000126	0.000186	CcSEcCtD
Linezolid—Pain—Doxorubicin—prostate cancer	0.000125	0.000185	CcSEcCtD
Linezolid—Constipation—Doxorubicin—prostate cancer	0.000125	0.000185	CcSEcCtD
Linezolid—MAOB—Metabolism—AKR1C3—prostate cancer	0.000125	0.000433	CbGpPWpGaD
Linezolid—Body temperature increased—Epirubicin—prostate cancer	0.000125	0.000185	CcSEcCtD
Linezolid—Abdominal pain—Epirubicin—prostate cancer	0.000125	0.000185	CcSEcCtD
Linezolid—MAOB—Metabolism—PRKACB—prostate cancer	0.000124	0.000431	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PDHA1—prostate cancer	0.000124	0.000429	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA3—prostate cancer	0.000124	0.000429	CbGpPWpGaD
Linezolid—MAOA—Metabolism—UCP3—prostate cancer	0.000124	0.000429	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TCN2—prostate cancer	0.000124	0.000429	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP17A1—prostate cancer	0.000123	0.000426	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—MDM2—prostate cancer	0.000121	0.000418	CbGpPWpGaD
Linezolid—Nausea—Prednisone—prostate cancer	0.00012	0.000178	CcSEcCtD
Linezolid—Gastrointestinal pain—Doxorubicin—prostate cancer	0.00012	0.000177	CcSEcCtD
Linezolid—MAOA—Metabolism—HSD3B1—prostate cancer	0.000118	0.000409	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC22A3—prostate cancer	0.000118	0.000409	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NCOA2—prostate cancer	0.000117	0.000406	CbGpPWpGaD
Linezolid—Urticaria—Doxorubicin—prostate cancer	0.000116	0.000172	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—prostate cancer	0.000116	0.000171	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—prostate cancer	0.000116	0.000171	CcSEcCtD
Linezolid—Asthenia—Epirubicin—prostate cancer	0.000113	0.000168	CcSEcCtD
Linezolid—MAOA—Metabolism—TBXAS1—prostate cancer	0.000113	0.000392	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA4—prostate cancer	0.000113	0.000392	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SLC5A5—prostate cancer	0.000112	0.000387	CbGpPWpGaD
Linezolid—Pruritus—Epirubicin—prostate cancer	0.000112	0.000166	CcSEcCtD
Linezolid—MAOA—Metabolism—GSTA2—prostate cancer	0.00011	0.000382	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2E1—prostate cancer	0.000109	0.000378	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SULT1A1—prostate cancer	0.000109	0.000377	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCG5—prostate cancer	0.000109	0.000377	CbGpPWpGaD
Linezolid—Diarrhoea—Epirubicin—prostate cancer	0.000108	0.00016	CcSEcCtD
Linezolid—MAOB—Metabolism—NQO1—prostate cancer	0.000108	0.000374	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TH—prostate cancer	0.000107	0.000369	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA1—prostate cancer	0.000106	0.000369	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP3A4—prostate cancer	0.000105	0.000365	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NAT2—prostate cancer	0.000105	0.000364	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HSD3B2—prostate cancer	0.000105	0.000364	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTO1—prostate cancer	0.000105	0.000364	CbGpPWpGaD
Linezolid—Asthenia—Doxorubicin—prostate cancer	0.000105	0.000155	CcSEcCtD
Linezolid—Dizziness—Epirubicin—prostate cancer	0.000105	0.000155	CcSEcCtD
Linezolid—MAOB—Metabolism—CYP1B1—prostate cancer	0.000104	0.000359	CbGpPWpGaD
Linezolid—Pruritus—Doxorubicin—prostate cancer	0.000103	0.000153	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000101	0.000349	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLCB2—prostate cancer	0.000101	0.000349	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LRP2—prostate cancer	0.000101	0.000349	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2C18—prostate cancer	0.000101	0.000349	CbGpPWpGaD
Linezolid—Vomiting—Epirubicin—prostate cancer	0.0001	0.000149	CcSEcCtD
Linezolid—MAOB—Metabolism—GGT1—prostate cancer	0.0001	0.000347	CbGpPWpGaD
Linezolid—Diarrhoea—Doxorubicin—prostate cancer	0.0001	0.000148	CcSEcCtD
Linezolid—Rash—Epirubicin—prostate cancer	9.97e-05	0.000148	CcSEcCtD
Linezolid—Dermatitis—Epirubicin—prostate cancer	9.96e-05	0.000147	CcSEcCtD
Linezolid—Headache—Epirubicin—prostate cancer	9.9e-05	0.000147	CcSEcCtD
Linezolid—MAOA—Metabolism—P4HB—prostate cancer	9.89e-05	0.000343	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NCOA1—prostate cancer	9.88e-05	0.000342	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP19A1—prostate cancer	9.74e-05	0.000337	CbGpPWpGaD
Linezolid—Dizziness—Doxorubicin—prostate cancer	9.67e-05	0.000143	CcSEcCtD
Linezolid—MAOA—Metabolism—SLC22A1—prostate cancer	9.62e-05	0.000333	CbGpPWpGaD
Linezolid—MAOB—Metabolism—RXRA—prostate cancer	9.4e-05	0.000326	CbGpPWpGaD
Linezolid—Nausea—Epirubicin—prostate cancer	9.39e-05	0.000139	CcSEcCtD
Linezolid—MAOA—Metabolism—SULT2A1—prostate cancer	9.38e-05	0.000325	CbGpPWpGaD
Linezolid—Vomiting—Doxorubicin—prostate cancer	9.3e-05	0.000138	CcSEcCtD
Linezolid—MAOA—Metabolism—MED12—prostate cancer	9.23e-05	0.00032	CbGpPWpGaD
Linezolid—Rash—Doxorubicin—prostate cancer	9.22e-05	0.000136	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—prostate cancer	9.21e-05	0.000136	CcSEcCtD
Linezolid—Headache—Doxorubicin—prostate cancer	9.16e-05	0.000136	CcSEcCtD
Linezolid—MAOA—Metabolism—GNG5—prostate cancer	9.15e-05	0.000317	CbGpPWpGaD
Linezolid—MAOB—Metabolism—COMT—prostate cancer	9.06e-05	0.000314	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTP1—prostate cancer	9.01e-05	0.000312	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ITPR1—prostate cancer	8.87e-05	0.000307	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NCOA3—prostate cancer	8.82e-05	0.000305	CbGpPWpGaD
Linezolid—Nausea—Doxorubicin—prostate cancer	8.69e-05	0.000129	CcSEcCtD
Linezolid—MAOA—Metabolism—HPGDS—prostate cancer	8.41e-05	0.000291	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TYMS—prostate cancer	8.38e-05	0.00029	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2C19—prostate cancer	8.36e-05	0.000289	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTM1—prostate cancer	8.28e-05	0.000287	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ACHE—prostate cancer	8.16e-05	0.000283	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTT1—prostate cancer	8.16e-05	0.000283	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LPL—prostate cancer	8.13e-05	0.000282	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2A6—prostate cancer	8.07e-05	0.000279	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP1A1—prostate cancer	7.85e-05	0.000272	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AKR1C3—prostate cancer	7.85e-05	0.000272	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PRKACB—prostate cancer	7.8e-05	0.00027	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ERCC2—prostate cancer	7.79e-05	0.00027	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP17A1—prostate cancer	7.72e-05	0.000267	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NCOA2—prostate cancer	7.36e-05	0.000255	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MTHFR—prostate cancer	7.32e-05	0.000253	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARA—prostate cancer	7.18e-05	0.000249	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SLC5A5—prostate cancer	7.02e-05	0.000243	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2E1—prostate cancer	6.86e-05	0.000237	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NQO1—prostate cancer	6.78e-05	0.000235	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CAV1—prostate cancer	6.75e-05	0.000234	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TH—prostate cancer	6.68e-05	0.000231	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP3A4—prostate cancer	6.61e-05	0.000229	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP1B1—prostate cancer	6.5e-05	0.000225	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GGT1—prostate cancer	6.3e-05	0.000218	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NCOA1—prostate cancer	6.2e-05	0.000215	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CG—prostate cancer	6.15e-05	0.000213	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP19A1—prostate cancer	6.11e-05	0.000212	CbGpPWpGaD
Linezolid—MAOA—Metabolism—RXRA—prostate cancer	5.9e-05	0.000204	CbGpPWpGaD
Linezolid—MAOB—Metabolism—INS—prostate cancer	5.82e-05	0.000202	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CREBBP—prostate cancer	5.7e-05	0.000197	CbGpPWpGaD
Linezolid—MAOA—Metabolism—COMT—prostate cancer	5.68e-05	0.000197	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTP1—prostate cancer	5.66e-05	0.000196	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ITPR1—prostate cancer	5.56e-05	0.000193	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CD—prostate cancer	5.41e-05	0.000187	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TYMS—prostate cancer	5.26e-05	0.000182	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTM1—prostate cancer	5.2e-05	0.00018	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NOS3—prostate cancer	5.11e-05	0.000177	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LPL—prostate cancer	5.1e-05	0.000177	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP1A1—prostate cancer	4.93e-05	0.000171	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ERCC2—prostate cancer	4.89e-05	0.000169	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CB—prostate cancer	4.71e-05	0.000163	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—prostate cancer	4.67e-05	0.000162	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTHFR—prostate cancer	4.59e-05	0.000159	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARA—prostate cancer	4.51e-05	0.000156	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CAV1—prostate cancer	4.24e-05	0.000147	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTEN—prostate cancer	4.07e-05	0.000141	CbGpPWpGaD
Linezolid—MAOB—Metabolism—EP300—prostate cancer	3.88e-05	0.000134	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CG—prostate cancer	3.86e-05	0.000134	CbGpPWpGaD
Linezolid—MAOA—Metabolism—INS—prostate cancer	3.65e-05	0.000126	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CREBBP—prostate cancer	3.58e-05	0.000124	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CD—prostate cancer	3.39e-05	0.000117	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NOS3—prostate cancer	3.2e-05	0.000111	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CB—prostate cancer	2.96e-05	0.000102	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—prostate cancer	2.93e-05	0.000101	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CA—prostate cancer	2.87e-05	9.95e-05	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTEN—prostate cancer	2.56e-05	8.85e-05	CbGpPWpGaD
Linezolid—MAOA—Metabolism—EP300—prostate cancer	2.44e-05	8.44e-05	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AKT1—prostate cancer	2.35e-05	8.13e-05	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CA—prostate cancer	1.8e-05	6.24e-05	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AKT1—prostate cancer	1.47e-05	5.1e-05	CbGpPWpGaD
